Casma Therapeutics, Inc., a biotechnology company engaging the autophagy and lysosomal systems to develop innovative new medicines, today announced that it has been awarded approximately $7.6 million ...
This Mario Day, join me in respecting the plumber by debating which titles in his rich catalog are best—am I wrong?